Studies on the regulation of protein kinase C by degradation of protein kinase C-activator
Studies on the regulation of protein kinase C by degradation of protein kinase C-activator
批准号:
61440031
负责人:
EGAWA KOHJI
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1986
资助国家:
日本
项目状态:
已结题
起止时间:
1986 至 1987
中文摘要
点击翻译按钮获取中文摘要
英文摘要
When TPA, an activator of protein kinase C (C-kinase) was added to cultured human or mouse fibroblasts, the cell conformation changed and EGF-bindingactivity of the cells decreased. However, such TPA effect disapeared after a while even when the cells still had large amount of bound TPA. At the sametime, the cells lost their reactivity to TPA. Removal of TPA from these cells by degradation brought bout recovery of the reactivity. Analyses of these phenomena were carried out and the results indicated that activation of C-kinase was followed by inactivation of the enzyme and that removal of the activator had a paradoxically positive role in the reactivation of C-kinase. On the otherhand, such positive effect of removal of TPA was not observed with regard tosuper oxide generation by TPA-stimulated polymorphonuclear leukocytes. These results seem to show that C-kinase is irreversibly inactivated after the activation and the supply of the enzyme is inhibited by TPA. Alternatively, it may be that inactivation is reversible and the enzyme acquires the original TPA-activatable status by removal of TPA. In vitro experiments using purified C-kinase was performed to analyze the mechanism of the recovery. They were notsuccessful, however, because contaminating calpain activity could not be removed from the enzyme preparation. A novel esterase which may take part in degradation of TPA in vivo, and therefore in activation of C-kinase during repeated administration of TPA, was demonstrated in sera from animals. The enzyme wasprufied from mouse serum and its enzymological, chemical and biological characteristics were clarified. The purified enzyme was utilized in the studies mentioned above. Also, an inhibitor specific for this esterase and which regulates the serum enzyme activity by co-existing with the esterase in the sera was found. It was of lipid nature and its partial purification and characterization was carried out.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
国内基金
海外基金
登录
查看更多内容
(PFTBA/BMSC)TPA@SFN-LP通过持续供氧及ROS清除促进糖尿病创面修复及毛囊再生
-
批准号:KLY25H180097
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郑鑫
-
依托单位:
血小板膜包被tPA mRNA-LNP载体的构建及其用于血栓预防的研究
-
批准号:32201155
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王松立
-
依托单位:
远隔缺血适应通过调控星形胶质细胞PDGF-CC/PDGFRα/p38 MAPK通路改善tPA静脉溶栓后脑血流自动调节功能的机制研究
-
批准号:--
-
项目类别:--
-
资助金额:52万元
-
批准年份:2022
-
负责人:郭珍妮
-
依托单位:
TPA通过上调miR-29b表达调节血神经屏障参与神经病理性疼痛的机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
tPA通过PAD4途径抑制中性粒细胞分泌NETs在预防静脉血栓栓塞复发中的作用研究
-
批准号:82202594
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:彭瑞
-
依托单位:
基于IRF5-IRF4轴调控小胶质细胞M1/M2型活化探讨利水渗湿中药改善tPA导致脑出血转化损伤的作用及机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:范祥
-
依托单位:
RGMa在缺血性脑卒中tPA治疗诱导的血脑屏障破坏和脑微血管血栓形成中的作用及机制研究
-
批准号:82101375
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:张融融
-
依托单位:
茯苓酸调控 PI3K 保护血脑屏障减轻 tPA 导致脑出血转化机制研究
-
批准号:LY22H280004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:范祥
-
依托单位:
LncRNA作为tPA治疗缺血性脑卒中后出血转化标志物及其调控机制与靶向治疗
-
批准号:82071316
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:巫嘉陵
-
依托单位:
参归三圣散通过调控VIP/VIPRs通路减缓缺血性脑卒中延迟tPA溶栓所致血脑屏障加重损害的研究
-
批准号:82074051
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:赵永华
-
依托单位: